Tumor Protein RNF128 Linked to Immune Resistance in Bladder Cancer
A new study links tumor-cell RNF128 to reduced CD8-positive T-cell infiltration and poorer immune checkpoint blockade responses in bladder cancer.
A new study links tumor-cell RNF128 to reduced CD8-positive T-cell infiltration and poorer immune checkpoint blockade responses in bladder cancer.
In the evolving landscape of cancer immunotherapy, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a groundbreaking treatment capable ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine